Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria

International Clinical Psychopharmacology

Volumn 14, Issue SUPPL. 2, 1999, Pages

  Eriksson, E ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Anger; Antidepressants; Irritability; Premenstrual dysphoria; Premenstrual dysphoric disorder; Premenstrual syndrome; Serotonin; Serotonin reuptake inhibitors

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; MAPROTILINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANGER; COMPULSION; CONFERENCE PAPER; DEPRESSION; DYSPHORIA; FEMALE; FOLLICULAR PHASE; HUMAN; IRRITABILITY; LUTEAL PHASE; MENSTRUATION; OBSESSION; OVULATION; PANIC; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SYMPTOM;

ADULT; FEMALE; HUMANS; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 0032802781     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. American Psychiatric Association (1994). Diagnostic and Statistic Manual of Mental Disorders. 4th revised edition (DSM-IV). Washington, DC: American Psychiatric Association, pp. 715-718.
2. Bäckström T, Hammarbäck S (1991). Premenstrual syndrome - psychiatric or gynaecological disorder. Annals Med 23:625-633.
3. Bloch M, Schmidt PJ, Su TP, Tobin MB, Rubinow DR (1998). Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls. Biol Psychiatry 43:897-903.
4. Brzezinski AA, Wurtman JJ, Wurtman RJ, Gleason R, Greenfield J, Nader T (1990). d-Fenfluramine suppresses the increased calorie and carbohydrate intake and improves the mood of women with premenstrual depression. Obstet Gynecol 76:296-301.
5. Eriksson E, Humble M, Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research (1990). In: The Biological Basin of Psychiatric Treatment. Progress in Basic Clinical Pharmacology. Pohl R, Gershon S (editors). Basel: Karger. pp. 66-119.
6. Eriksson E, Lisjö P, Sundblad C, Andersson K, Andersch B, Modigh K (1990). Effect of clomipramine in the premenstrual syndrome. Acta Psych Scand 81:87-88.
7. Eriksson E, Sundblad C, Lisjö P, Modigh K, Andersch B (1992). Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 17:195-204.
8. Eriksson E, Alling C, Andersch, Andersson K, Berggren U (1994). Cerebrospinal fluid levels of monoamine metabolites. Neuropsychopharmacology 11:201-213.
9. Eriksson E, Hedberg A, Andersch B, Sundblad C (1995). The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 12:167-176.
10. Eriksson E, Sundblad C, Yookers K, Steiner M (1999). Premenstrual dysphoria and related conditions: symptomatology, pathophysiology, and treatment. In: Mood Disorders in Women. Steiner M, Yonkers K, Eriksson E (editors). London: Martin Dunitz.
11. Fitzgerald M, Malone KM, Li S (1997). Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am J Psychiatry 154:556-558.
12. Freeman EW, Rickels K, Sondheimer SJ, Wittmaack FM (1996). Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial. J Clin Psychiatry 57:7-11.
13. Halbreich U, Smoller JW (1997). Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 58:399-402.
14. Menkes DB, Taghavi E, Mason PA (1992). Fluoxetine treatment of severe premenstrual syndrome. BMJ 305:346-347.
15. Menkes DB, Coates DC, Fawcett JP (1994). Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 32:37-44.
16. Ozeren S, Corakei A, Yucesoy I, Mercan R, Erhan G (1997). Fluoxetine in the treatment of premenstrual syndrome. Eur J Obstet Gynecol Reprod Biol 73:167-170.
17. Pearlstein TB, Stone AB, Lund SA (1997). Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol 17:261-266.
18. Rickels K, Freedman EW, Sonderheimer S, Albert J (1989). Fluoxetine in the treatment of premenstrual syndrome. Curr Ther Res 48:161-166.
19. Rickels K, Freeman E, Sondheimer S (1998). Buspirone in treatment of premenstrual syndrome. Lancet 1:777.
20. Rubinow DR, Roy-Byrne P, Hoban MC, Grover GN, Stambler N, Post RM (1986). Premenstrual mood changes. Characteristic patterns in women with and without premenstrual syndrome. J Affect Disord 10:85-90.
21. Schmidt PJ, Lynnette KN, Grover GN, Muller KL, Merriam GR, Rubinow DR (1991). Lack of effect of induced menses on symptoms in women with premenstrual. N Engl J Med 324:1174-1179.
22. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209-216.
23. Steinberg S, Annable L, Young SN, Belanger MC (1994). Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study. J Psychiatr Neurosci 19:114-119.
24. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. (1995). Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 332:1529-1534.
25. Steiner M, Korzekwa M, Lamont J, Wilkins A (1997). Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 33:771-774.
26. Stone AB, Pearlstein TB, Brown WA (1991). Fluoxetine in the treatment of late luteal phase dysphoric disorder. J Clin Psychiatry 52:290-293.
27. Su TP, Schmidt PJ, Danaccau M, Murphy DL, Rubinow DR (1997a). Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylalanine in women with premenstrual syndrome and controls. J Clin Endocrin Metab 82:1220-1228.
28. Su TP, Schmidt PJ, Danaceau MA, Tobin MB, Rosenstein DL, Murphy DL, Rubinow DR (1997b). Fluoxetine in the treatment of premenstrual dysphoria. Neuropsychopharmacology 16:346-356.
29. Sundblad C, Modigh K, Andersch B, Eriksson E (1992). Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial. Acta Psych Scand 85:39-47.
30. Sundblad C, Hedberg MA, Eriksson E (1993). Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 9:133-45.
31. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson, Eriksson E (1998). Citalopram in premenstrual dysphoric disorder: is intermittent treatment more effective than continuous drug administration? J Clin Psychopharm 18:390-398.
32. Taghavi E, Menkes DB, Howard RC, Mason PA, Shaw JP, Spears GF (1995). Premenstrual syndrome: a double-blind controlled trial of desipramine and metylscopolamine. Int Clin Psychopharmacol 10:119-122.
33. Wood SH, Mortola JF, Chan YF, Moossazadeh F, Yen SS (1992). Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol 80:339-344.
34. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. (1997). Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. JAMA 278:983-988.
35. Young SA, Hurt PH, Bencdek DM, Howard RS (1998). Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 59:76-80.